Attached files

file filename
EX-23 - EX-23 - AMERISOURCEBERGEN CORPa2226704zex-23.htm
EX-21 - EX-21 - AMERISOURCEBERGEN CORPa2226704zex-21.htm
EX-32 - EX-32 - AMERISOURCEBERGEN CORPa2226704zex-32.htm
EX-31.2 - EX-31.2 - AMERISOURCEBERGEN CORPa2226704zex-31_2.htm
EX-31.1 - EX-31.1 - AMERISOURCEBERGEN CORPa2226704zex-31_1.htm
EX-10.25 - EX-10.25 - AMERISOURCEBERGEN CORPa2226704zex-10_25.htm
EX-10.29 - EX-10.29 - AMERISOURCEBERGEN CORPa2226704zex-10_29.htm
EX-10.33 - EX-10.33 - AMERISOURCEBERGEN CORPa2226704zex-10_33.htm
EX-10.34 - EX-10.34 - AMERISOURCEBERGEN CORPa2226704zex-10_34.htm
10-K - 10-K - AMERISOURCEBERGEN CORPa2226704z10-k.htm

QuickLinks -- Click here to rapidly navigate through this document


Exhibit 12

AmerisourceBergen Corporation
Computation of Ratio of Earnings to Fixed Charges

 
  Fiscal Year Ended September 30,  
(in thousands, except ratios)
  2011   2012   2013   2014   2015  

Determination of earnings:

                               

Income from continuing operations before income taxes

  $ 1,117,989   $ 1,216,873   $ 824,458   $ 673,428   $ 274,149  

Add:

                               

Loss on equity investments

    607     380     113     172     30,833  

Fixed charges (excluding capitalized interest)

    85,960     103,746     86,989     89,977     115,314  

Amortization of capitalized interest

    1,193     1,443     1,635     1,676     1,676  

Total earnings available for fixed charges

  $ 1,205,749   $ 1,322,442   $ 913,195   $ 765,253   $ 421,972  

Fixed charges:

                               

Interest expense

  $ 78,329   $ 94,369   $ 75,047   $ 77,703   $ 101,986  

Capitalized interest

    3,367     504              

Estimated interest portion of rent expense

    7,631     9,377     11,942     12,274     13,328  

Total fixed charges

  $ 89,327   $ 104,250   $ 86,989   $ 89,977   $ 115,314  

Ratio of earnings to fixed charges(1)

    13.5     12.7     10.5     8.5     3.7  

(1)
For purposes of computing the above ratios:

Earnings include warrant expense, a non-cash expense, of $90.1 million, $422.7 million and $912.7 million in the fiscal years ended September 30, 2013, 2014, and 2015, respectively.

Loss on equity investments includes an impairment charge of $30.6 million in fiscal 2015 related to the Company's minority interest in a pharmaceutical wholesaler in Brazil. There was no such impairment charge recorded in the fiscal years ended September 30, 2011, 2012, 2013, and 2014, respectively.



QuickLinks

AmerisourceBergen Corporation Computation of Ratio of Earnings to Fixed Charges